SMTL ID : 7z6z.2 (1 other biounit)

Crystal structure of Angiotensin-1 converting enzyme N-domain in complex with fosinoprilat

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.75 Å

Oligo State

monomer

Ligands

1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-FUC.1: 10 residues within 4Å: Chain A: E.403, N.416, D.417, T.418, D.421, E.522, G.523, P.524, Q.527, L.576 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:D.417, A:T.418

1 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-FUC.2: 7 residues within 4Å: Chain A: E.161, V.477, T.478, N.480, T.482, H.483, L.603 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:T.478, A:T.478 Water bridges: A:E.161, A:T.478, A:T.478

1 x KS8: fosinoprilat(Non-covalent)

KS8.3: 27 residues within 4Å: Chain A: D.43, Q.259, H.331, A.332, S.333, A.334, W.335, S.357, T.358, H.361, E.362, H.365, Y.369, E.389, D.393, K.432, F.435, K.489, F.490, H.491, T.496, Y.498, Y.501, F.505 Ligands: PEG.5, PEG.6, ZN.15 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:W.335, A:H.361, A:F.490, A:T.496, A:Y.501, A:F.505 Hydrogen bonds: A:Q.259, A:H.331, A:Y.498 Water bridges: A:K.489, A:K.489, A:Y.501 Salt bridges: A:H.331, A:K.489, A:H.491 pi-Stacking: A:W.335

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.4: 7 residues within 4Å: Chain A: N.45, T.47, E.49, N.50, R.53, D.324, R.326 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:N.45, A:T.47, A:N.50 Water bridges: A:T.47, A:A.48

3 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)

PEG.5: 9 residues within 4Å: Chain A: V.36, S.39, A.334, W.335, D.336, Y.338, Y.369 Ligands: KS8.3, PEG.6 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:S.39, A:S.39, A:D.336, A:Y.369 PEG.6: 13 residues within 4Å: Chain A: Y.338, H.365, Y.369, Y.372, R.380, R.381, G.382, H.388, E.389, R.500 Ligands: KS8.3, PEG.5, EDO.19 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:Y.338 Water bridges: A:A.334, A:G.382, A:E.389, A:R.500 PEG.13: 4 residues within 4Å: Chain A: L.284, Q.285, Q.286, G.287 No protein-ligand interaction detected (PLIP)

8 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.7: 4 residues within 4Å: Chain A: R.96, D.189, G.190, F.191 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:R.96, A:D.189, A:G.190 EDO.17: 2 residues within 4Å: Ligands: EDO.18, CA.24 No protein-ligand interaction detected (PLIP) EDO.18: 8 residues within 4Å: Chain A: H.234, R.235, R.236, G.238, D.239 Ligands: ACT.14, EDO.17, CA.24 No protein-ligand interaction detected (PLIP) EDO.19: 5 residues within 4Å: Chain A: W.201, R.381, P.385, R.500 Ligands: PEG.6 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:R.381 EDO.20: 4 residues within 4Å: Chain A: K.407, D.529, Y.531, R.532 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:K.407, A:Y.531, A:R.532 EDO.21: 5 residues within 4Å: Chain A: R.240, Y.241, L.603, P.604, D.605 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:R.240, A:Y.241, A:Y.241, A:D.605 EDO.22: 4 residues within 4Å: Chain A: W.599, H.600, P.601, P.602 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:W.599, A:H.600 Water bridges: A:H.600 EDO.23: 6 residues within 4Å: Chain A: V.127, C.128, F.158, E.161, G.162, Y.607 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:F.158, A:E.161 Water bridges: A:N.165

6 x ACT: ACETATE ION(Non-functional Binders)

ACT.8: 2 residues within 4Å: Chain A: E.176, D.177 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:E.176 ACT.9: 5 residues within 4Å: Chain A: E.513, D.566, Q.568, P.569, K.572 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:Q.568 ACT.10: 3 residues within 4Å: Chain A: E.298, T.302, P.308 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:E.298, A:T.302 ACT.11: 3 residues within 4Å: Chain A: T.291, R.295, W.314 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:R.295 ACT.12: 5 residues within 4Å: Chain A: A.51, E.55, A.113, S.116, Q.117 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:Q.117 Hydrogen bonds: A:Q.117 ACT.14: 5 residues within 4Å: Chain A: H.234, G.238, D.239 Ligands: EDO.18, CA.24 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:D.239 Hydrogen bonds: A:D.239

1 x ZN: ZINC ION(Non-covalent)

ZN.15: 5 residues within 4Å: Chain A: H.361, H.365, E.389, Y.501 Ligands: KS8.3 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.361, A:H.365, A:E.389

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.16: 6 residues within 4Å: Chain A: W.201, Y.202, P.385, P.497, I.499, R.500 Ligand excluded by PLIP

2 x CA: CALCIUM ION(Non-functional Binders)(Non-covalent)

CA.24: 3 residues within 4Å: Ligands: ACT.14, EDO.17, EDO.18 No protein-ligand interaction detected (PLIP) CA.25: 4 residues within 4Å: Chain A: S.260, E.262, N.263, D.354 5 PLIP interactions: 2 interactions with chain A, 3 Ligand-Water interactions Metal complexes: A:E.262, A:D.354, H2O.1, H2O.5, H2O.11

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cozier, G.E. et al., Structural basis for the inhibition of human angiotensin-1 converting enzyme by fosinoprilat. Febs J. (2022)

Release Date

2022-06-22

Peptides

Angiotensin-converting enzyme, soluble form: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Angiotensin-converting enzyme, soluble form

Related Entries With Identical Sequence